Akums Drugs and Pharmaceuticals Financial Results
- Market cap
- ₹12,629 crore
- P/E
- 43.3
- P/B
- 3.81
- ROE
- 8.0%
- Dividend yield
- 0.36%
For the year ended Mar 2023, Akums Drugs and Pharmaceuticals reported revenue of ₹3,475 crore and net profit of ₹98 crore, against ₹4,020 crore and ₹1 crore a year earlier.
Akums Drugs and Pharmaceuticals annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | 3,475 | 4,020 | 4,071 | 4,251 | 4,502 |
| Expenses | 3,171 | 3,534 | 3,607 | 3,723 | 3,934 |
| Operating profit | 304 | 486 | 464 | 529 | 568 |
| Operating margin % | 9% | 12% | 11% | 12% | 13% |
| Other income | 5 | -355 | 65 | 97 | 109 |
| Interest | 46 | 50 | 30 | 89 | 92 |
| Depreciation | 113 | 126 | 153 | 155 | 159 |
| Profit before tax | 150 | -45 | 345 | 382 | 426 |
| Tax % | 35% | 102% | 0% | 33% | 31% |
| Net profit | 98 | 1 | 344 | 256 | 293 |
| EPS (₹) | 6.20 | -0.26 | 22.09 | 16.67 | 19.05 |
| Dividend payout % | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Akums Drugs and Pharmaceuticals financial results — frequently asked questions
What is Akums Drugs and Pharmaceuticals' annual revenue and net profit?
For the financial year ended Mar 2023, Akums Drugs and Pharmaceuticals' revenue was ₹3,475 crore and net profit ₹98 crore; net profit rose 9,700.00% from ₹1 crore in Mar 2024.
How fast has Akums Drugs and Pharmaceuticals grown over three years?
From Mar 2026 to Mar 2023, Akums Drugs and Pharmaceuticals' revenue grew at a compound annual rate of -6.5% and net profit at -27.4%. Past growth does not indicate future results.
What is the EPS of Akums Drugs and Pharmaceuticals?
Annual EPS for Mar 2023 was ₹6.20.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Akums Drugs and Pharmaceuticals With ATS
Track AKUMS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.